Segregation analysis of apolipoprotein A1 levels in families of adolescents: A community-based study in Taiwan

BMC Genetics

Volumn 7, Issue , 2006, Pages

  Chien, Kuo Liong ^a,b   Chen, Wei J ^a,b   Hsu, Hsiu Ching ^b   Su, Ta Chen ^b   Chen, Meng Fong ^b   Lee, Yuan Teh ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1;

ADOLESCENT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHILD PARENT RELATION; CORRELATION ANALYSIS; FEMALE; GENDER; GENETIC ANALYSIS; HUMAN; IMMUNOASSAY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN VARIANT; RURAL POPULATION; SEGREGATION ANALYSIS; SIBLING RELATION; SMOKING; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TAIWAN; TURBIDIMETRY; ADULT; BIOLOGICAL MODEL; BLOOD; CHROMOSOME SEGREGATION; GENETICS; PROSPECTIVE STUDY; QUANTITATIVE TRAIT;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; BODY MASS INDEX; CHROMOSOME SEGREGATION; FEMALE; HUMANS; MALE; MODELS, GENETIC; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT, HERITABLE; TAIWAN;

EID: 32144437603     PISSN: 14712156     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2156-7-4     Document Type: Article

References (40)

1. Graffagnino C: Molecular genetics of lipid metabolism. In Genetics of Cerebrovascular Disease Edited by: Alberts MJ. New York: Futura Publishing; 1999:81-115.
2. Humphries SE, Peacock R, Gudnason V: Genetic determinants of hyperlipidemia. In Lipoproteins in Health and Disease Edited by: Betteridge DJ, Illingworth DR, Shepherd J. London: Oxford University Press; 1999:127-162.
3. Breslow JL: Human apolipoprotein molecular biology and genetic variation. Annu Rev Biochem 1985, 54:699-727.
4. Franceschini G, Sirtori CR, Capurso A, Weisgraber KH, Mahley RW: A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 1980, 66:892-900.
5. Srinivasan SR, Berenson GS: Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 1995, 41:159-164.
6. Brunner EJ, Marmot MG, White IR, O'Brien JR, Etherington MD, Slavin BM, Kearney EM, Smith GD: Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 1993, 102:195-207.
7. Moll PP, Michels VV, Weidman WH, Kottke BA: Genetic determination of plasma apolipoprotein Al in a population-based sample. Am J Hum Genet 1989, 44:124-139.
8. Juo SHH, Beaty TH, Duffy DL, Coresh J, Kwiterovich PO: No common major gene for apolipoprotein A-I and HDL3-C levels: Evidence from bivariate segregation analysis. Genet Epidemiol 1999, 16:54-68.
9. Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M: Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 1987, 7:421-425.
10. Sistonen P, Ehnholm C: On the heritability of serum high density lipoprotein in twins. Am J Hum Genet 1987, 32:1-7.
11. Jarvik GP: Complex segregation analyses: uses and limitations. Am J Hum Genet 1998, 63:942-946.
12. Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MRE, Hopper JL: After BIRCA1 and BRCA2 what is next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 2001, 68:420-431.
13. Amos CI, Elston RC, Srinivasan SR, Wilson AF, Cresanta JL, Ward LJ, Berenson GS: Linkage and segregation analyses of apolipoproteins Al and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study. Genet Epidemiol 1987, 4:115-128.
14. Borecki IB, Laskarzewski P, Rao DC: Genetic factors influencing apolipoprotein Al and All levels in a kindred with premature coronary heart disease. Genet Epidemiol 1988, 5:393-406.
15. Prenger VL, Beaty TH, Kwiterovich PO: Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-I plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 1992, 51: 1047-1057.
16. Blangero J, Williams-Blangero S, Mahaney MC: Multivariate genetic analysis of apo Al concentration and HDL subfractions: evidence for major locus pleiotropy. Genet Epidemiol 1993, 10:617-622.
17. Blangero J, Williams-Blangero S, Mahaney MC, Comuzzie AG, Hixson JE, Samollow PB, Sharp RM, Stern MP, Maccluer JW: Effects of a major gene for apolipoprotein A-I concentration are thyroid hormone dependent in Mexican Americans. Arterioscler Thromb Vasc Biol 1996, 16:1177-1183.
18. An P, Rice T, Gagnon J, Borecki IB, Bergeron J, Despres JP, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC: Segregation analysis of apolipoproteins A-I and B-100 measured before and after an exercise training program: the HERITAGE Family Study. Arterioscler Thromb Vosc Biol 2000, 20:807-814.
19. Friedlander Y, Kark JD, Cohen T, Eisenberg S, Stein Y: Admixture analysis of high density lipoprotein cholesterol distribution in a Jerusalem population sample. Clin Genet 1983, 24:117-127.
20. Hamsten A, Iselius L, Dahlen G, de Faire U: Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. Atherosclerosis 1986, 60:199-208.
21. Lamon-Fava F, Jimenez D, Christian JC, Fabsitz RR, Reed TE, Carmelli D, Castelli WP, Ordovas JM, Wilson PWF, Schaefer EJ: The NHLBI twin study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 1991, 91:97-106.
22. Namboodiri KK, Green PP, Kaplan EB, Tyroler HA, Morrison JA, Chase GA, Elston RC, Rifkind BM, Glueck CJ: Family aggregation of high density lipoprotein cholesterol. Collaborative lipid research clinics program family study. Arteriosclerosis 1983, 3:616-626.
23. Pyke SD, Wood DA, Kinmonth AL, Thompson SG: Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study. Arch Fam Med 1997, 6:354-360.
24. Bucher KD, Kaplan EB, Namboodiri KK, Glueck CJ, Laskarzewski P, Rifkind BM: Segregation analysis of low levels of high-density lipoprotein cholesterol in the Collaborative Lipid Research Clinics Program Family Study. Am J Hum Genet 1987, 40:489-502.
25. Kovacs P, van den BJ, Kloting I: Effects of quantitative trait loci for lipid phenotypes in the rat are influenced by age. Clin Exp Pharmocol Physiol 1998, 25:1004-1007.
26. Boomsma DI, Kempen HJ, Gevers LJ, Havekes L, de Knijff P, Frants RR: Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents. Genet Epidemiol 1996, 13:49-60.
27. Lee YT, Lin RS, Sung FC, Yang CY, Chien KL, Chen WJ, Su TC, Hsu HC, Huang YC: Chin-Shan Community Cardiovascular Cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 2000, 53:836-846.
28. Chien KL, Sung FC, Hsu HC, Su TC, Lee YT: Left ventricular mass and correlated atherosclerotic risk factors in young adolescents: Report from Chin-Shan Community Cardiovascular Study in Taiwan. Atherosclerosis 2001, 155:431-437.
29. Chien KL, Lee YT, Sung FC, Hsu HC, Su TC, Lin RS: Hyperinsulinemia and related atherosclerotic risk factors in the population at cardiovascular risk: a community-based study. Clin Chem 1999, 45:838-846.
30. Wieland H, Seidel D: A simple specific method for precipitation of low density lipoprotein. J Lipid Res 1983, 24:904-905.
31. + precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28:1379-1388.
32. Statistical Analysis for Genetic Epidemiology, Release 3.1 Computer program package available from the Department of Epidemiology and Biostatistics, Cleveland, OH, USA. Rammelkamp Center for Education and Research, MetroHelath Campus, Case Western Reserve University; 1997.
33. Cloninger CR, von Knorring L, Creland L: Pentametric distribution of platelet monoamine oxiclase activity. Psychiatry Res 1985, 15:133-143.
34. Demenais FM, Bonney GE: Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits. Genet Epidemiol 1989, 6:597-617.
35. Akaike H: A new look at the statistical model identification. IEEE Trans Automat Control 1974, 19:716-723.
36. MacLean CJ, Morton NE, Lew R: Analysis of family resemblance. IV. Operational characteristics of segregation analysis. Am J Hum Genet 1975, 27:365-384.
37. Demenais F, Lathrop M, Lalouel JM: Robustness and power of the unified model in the analysis of quantitative measurements. Am J Hum Genet 1986, 39:228-234.
38. Atwood LD, Kammerer CM, Mitchell BD: Exploring the HDL likelihood surface. Genet Elpidemiol 1993, 10:641-645.
39. Juo SH, Beaty TH, Kwiterovich POJ: Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease. Arterioscler Thromb Vosc Biol 1997, 17:2729-2736.
40. Kraft P, de AM: Group 6: Pleiotropy and multivariate analysis. Genet Epidemiol 2003, 25(Suppl 1):S50-S56.